nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—Prednisone—hematologic cancer	0.21	0.506	CrCtD
Exemestane—Prednisolone—hematologic cancer	0.205	0.494	CrCtD
Exemestane—CYP19A1—Betamethasone—hematologic cancer	0.031	0.156	CbGbCtD
Exemestane—CYP19A1—Dexamethasone—hematologic cancer	0.018	0.091	CbGbCtD
Exemestane—CYP3A4—Bexarotene—hematologic cancer	0.0124	0.0624	CbGbCtD
Exemestane—CYP3A4—Lomustine—hematologic cancer	0.0115	0.058	CbGbCtD
Exemestane—CYP3A4—Busulfan—hematologic cancer	0.0115	0.058	CbGbCtD
Exemestane—Testolactone—Betamethasone—hematologic cancer	0.0106	0.0422	CrCrCtD
Exemestane—Testolactone—Dexamethasone—hematologic cancer	0.0106	0.0422	CrCrCtD
Exemestane—Testolactone—Triamcinolone—hematologic cancer	0.0103	0.0412	CrCrCtD
Exemestane—CYP3A4—Thiotepa—hematologic cancer	0.0102	0.0517	CbGbCtD
Exemestane—Testolactone—Prednisone—hematologic cancer	0.00981	0.0391	CrCrCtD
Exemestane—Testolactone—Prednisolone—hematologic cancer	0.00957	0.0382	CrCrCtD
Exemestane—Prednisone—Betamethasone—hematologic cancer	0.00947	0.0378	CrCrCtD
Exemestane—Prednisone—Dexamethasone—hematologic cancer	0.00947	0.0378	CrCrCtD
Exemestane—Prednisone—Triamcinolone—hematologic cancer	0.00925	0.0369	CrCrCtD
Exemestane—CYP19A1—ovarian follicle—hematologic cancer	0.00889	0.665	CbGeAlD
Exemestane—Loteprednol—Dexamethasone—hematologic cancer	0.00879	0.0351	CrCrCtD
Exemestane—Loteprednol—Betamethasone—hematologic cancer	0.00879	0.0351	CrCrCtD
Exemestane—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00879	0.0351	CrCrCtD
Exemestane—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00879	0.0351	CrCrCtD
Exemestane—Loteprednol—Triamcinolone—hematologic cancer	0.00859	0.0343	CrCrCtD
Exemestane—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00859	0.0343	CrCrCtD
Exemestane—Prednisone—Prednisolone—hematologic cancer	0.00857	0.0342	CrCrCtD
Exemestane—Methylprednisolone—Betamethasone—hematologic cancer	0.00822	0.0328	CrCrCtD
Exemestane—Methylprednisolone—Dexamethasone—hematologic cancer	0.00822	0.0328	CrCrCtD
Exemestane—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00815	0.0325	CrCrCtD
Exemestane—Loteprednol—Prednisone—hematologic cancer	0.00815	0.0325	CrCrCtD
Exemestane—Prednisolone—Dexamethasone—hematologic cancer	0.00805	0.0321	CrCrCtD
Exemestane—Prednisolone—Betamethasone—hematologic cancer	0.00805	0.0321	CrCrCtD
Exemestane—Methylprednisolone—Triamcinolone—hematologic cancer	0.00803	0.0321	CrCrCtD
Exemestane—CYP3A4—Methoxsalen—hematologic cancer	0.00796	0.0402	CbGbCtD
Exemestane—Loteprednol—Prednisolone—hematologic cancer	0.00796	0.0318	CrCrCtD
Exemestane—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00796	0.0318	CrCrCtD
Exemestane—Prednisolone—Triamcinolone—hematologic cancer	0.00786	0.0314	CrCrCtD
Exemestane—Methylprednisolone—Prednisone—hematologic cancer	0.00762	0.0304	CrCrCtD
Exemestane—CYP3A4—Bortezomib—hematologic cancer	0.00757	0.0382	CbGbCtD
Exemestane—Prednisolone—Prednisone—hematologic cancer	0.00746	0.0298	CrCrCtD
Exemestane—Testosterone—Prednisolone—hematologic cancer	0.00744	0.0297	CrCrCtD
Exemestane—Methylprednisolone—Prednisolone—hematologic cancer	0.00744	0.0297	CrCrCtD
Exemestane—CYP3A4—Daunorubicin—hematologic cancer	0.00724	0.0366	CbGbCtD
Exemestane—CYP3A4—Cytarabine—hematologic cancer	0.00639	0.0323	CbGbCtD
Exemestane—CYP3A4—Teniposide—hematologic cancer	0.00629	0.0318	CbGbCtD
Exemestane—CYP3A4—Ifosfamide—hematologic cancer	0.00581	0.0293	CbGbCtD
Exemestane—CYP3A4—Imatinib—hematologic cancer	0.00555	0.028	CbGbCtD
Exemestane—CYP3A4—Ruxolitinib—hematologic cancer	0.00523	0.0264	CbGbCtD
Exemestane—CYP3A4—Nilotinib—hematologic cancer	0.00504	0.0255	CbGbCtD
Exemestane—CYP3A4—Vinorelbine—hematologic cancer	0.005	0.0252	CbGbCtD
Exemestane—CYP3A4—Triamcinolone—hematologic cancer	0.00457	0.0231	CbGbCtD
Exemestane—CYP3A4—Dasatinib—hematologic cancer	0.00446	0.0225	CbGbCtD
Exemestane—CYP3A4—Mitoxantrone—hematologic cancer	0.0044	0.0222	CbGbCtD
Exemestane—CYP3A4—Betamethasone—hematologic cancer	0.00392	0.0198	CbGbCtD
Exemestane—CYP3A4—Prednisolone—hematologic cancer	0.00387	0.0195	CbGbCtD
Exemestane—CYP3A4—Prednisone—hematologic cancer	0.00366	0.0185	CbGbCtD
Exemestane—CYP3A4—Irinotecan—hematologic cancer	0.00347	0.0175	CbGbCtD
Exemestane—CYP3A4—Vinblastine—hematologic cancer	0.00308	0.0156	CbGbCtD
Exemestane—CYP3A4—Vincristine—hematologic cancer	0.00303	0.0153	CbGbCtD
Exemestane—CYP3A4—Etoposide—hematologic cancer	0.00278	0.014	CbGbCtD
Exemestane—CYP3A4—Dexamethasone—hematologic cancer	0.00228	0.0115	CbGbCtD
Exemestane—CYP3A4—Doxorubicin—hematologic cancer	0.00189	0.00956	CbGbCtD
Exemestane—CYP19A1—hematopoietic system—hematologic cancer	0.00107	0.0803	CbGeAlD
Exemestane—CYP19A1—gonad—hematologic cancer	0.000816	0.061	CbGeAlD
Exemestane—CYP19A1—blood—hematologic cancer	0.000711	0.0532	CbGeAlD
Exemestane—CYP19A1—testis—hematologic cancer	0.000588	0.044	CbGeAlD
Exemestane—CYP3A4—hematopoietic system—hematologic cancer	0.00052	0.0389	CbGeAlD
Exemestane—CYP19A1—lymph node—hematologic cancer	0.000426	0.0319	CbGeAlD
Exemestane—CYP3A4—blood—hematologic cancer	0.000345	0.0258	CbGeAlD
Exemestane—Estropipate—SLC22A1—hematologic cancer	0.000182	0.106	CrCbGaD
Exemestane—Conjugated Estrogens—ABCC3—hematologic cancer	0.000164	0.0948	CrCbGaD
Exemestane—Loteprednol—NR3C1—hematologic cancer	0.000161	0.0931	CrCbGaD
Exemestane—Estropipate—ESR1—hematologic cancer	0.000125	0.0723	CrCbGaD
Exemestane—Methylprednisolone—NR3C1—hematologic cancer	0.0001	0.058	CrCbGaD
Exemestane—Conjugated Estrogens—ABCG2—hematologic cancer	7.94e-05	0.046	CrCbGaD
Exemestane—Estrone—ABCG2—hematologic cancer	7.92e-05	0.0459	CrCbGaD
Exemestane—Conjugated Estrogens—ESR1—hematologic cancer	7.78e-05	0.0451	CrCbGaD
Exemestane—Estrone—ESR1—hematologic cancer	7.76e-05	0.045	CrCbGaD
Exemestane—Prednisone—NR3C1—hematologic cancer	7.65e-05	0.0443	CrCbGaD
Exemestane—Prednisolone—NR3C1—hematologic cancer	7.05e-05	0.0409	CrCbGaD
Exemestane—Testosterone—SLC22A1—hematologic cancer	6.89e-05	0.04	CrCbGaD
Exemestane—Testosterone—AR—hematologic cancer	6.12e-05	0.0355	CrCbGaD
Exemestane—Estropipate—ALB—hematologic cancer	5.55e-05	0.0322	CrCbGaD
Exemestane—Methylprednisolone—ABCB1—hematologic cancer	4.83e-05	0.028	CrCbGaD
Exemestane—Testosterone—ABCG2—hematologic cancer	4.82e-05	0.0279	CrCbGaD
Exemestane—Prednisone—ALB—hematologic cancer	3.87e-05	0.0224	CrCbGaD
Exemestane—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hematologic cancer	3.83e-05	0.0465	CbGpPWpGaD
Exemestane—Prednisone—ABCB1—hematologic cancer	3.69e-05	0.0214	CrCbGaD
Exemestane—CYP19A1—FSH signaling pathway—SGK1—hematologic cancer	3.64e-05	0.0441	CbGpPWpGaD
Exemestane—Estrone—ALB—hematologic cancer	3.45e-05	0.02	CrCbGaD
Exemestane—Prednisolone—ABCB1—hematologic cancer	3.4e-05	0.0197	CrCbGaD
Exemestane—Conjugated Estrogens—ABCB1—hematologic cancer	3.31e-05	0.0192	CrCbGaD
Exemestane—Estrone—ABCB1—hematologic cancer	3.3e-05	0.0191	CrCbGaD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hematologic cancer	3.13e-05	0.038	CbGpPWpGaD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	2.22e-05	0.0269	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—EIF4EBP1—hematologic cancer	2.2e-05	0.0267	CbGpPWpGaD
Exemestane—Testosterone—ALB—hematologic cancer	2.1e-05	0.0122	CrCbGaD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	2.09e-05	0.0253	CbGpPWpGaD
Exemestane—Testosterone—ABCB1—hematologic cancer	2e-05	0.0116	CrCbGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—MLH1—hematologic cancer	1.92e-05	0.0233	CbGpPWpGaD
Exemestane—Paraesthesia—Betamethasone—hematologic cancer	1.49e-05	0.000124	CcSEcCtD
Exemestane—Mental disorder—Methotrexate—hematologic cancer	1.49e-05	0.000124	CcSEcCtD
Exemestane—Rash—Gemcitabine—hematologic cancer	1.49e-05	0.000124	CcSEcCtD
Exemestane—Dermatitis—Gemcitabine—hematologic cancer	1.48e-05	0.000124	CcSEcCtD
Exemestane—Hypersensitivity—Etoposide—hematologic cancer	1.48e-05	0.000123	CcSEcCtD
Exemestane—Haemoglobin—Doxorubicin—hematologic cancer	1.48e-05	0.000123	CcSEcCtD
Exemestane—Headache—Gemcitabine—hematologic cancer	1.48e-05	0.000123	CcSEcCtD
Exemestane—Nausea—Vincristine—hematologic cancer	1.48e-05	0.000123	CcSEcCtD
Exemestane—Cardiac disorder—Epirubicin—hematologic cancer	1.47e-05	0.000123	CcSEcCtD
Exemestane—Rhinitis—Doxorubicin—hematologic cancer	1.47e-05	0.000123	CcSEcCtD
Exemestane—Haemorrhage—Doxorubicin—hematologic cancer	1.47e-05	0.000122	CcSEcCtD
Exemestane—Hepatitis—Doxorubicin—hematologic cancer	1.47e-05	0.000122	CcSEcCtD
Exemestane—Hypersensitivity—Prednisolone—hematologic cancer	1.46e-05	0.000122	CcSEcCtD
Exemestane—Hypoaesthesia—Doxorubicin—hematologic cancer	1.46e-05	0.000122	CcSEcCtD
Exemestane—Pharyngitis—Doxorubicin—hematologic cancer	1.46e-05	0.000121	CcSEcCtD
Exemestane—Dyspepsia—Betamethasone—hematologic cancer	1.46e-05	0.000121	CcSEcCtD
Exemestane—Dyspepsia—Dexamethasone—hematologic cancer	1.46e-05	0.000121	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—CCND2—hematologic cancer	1.46e-05	0.0177	CbGpPWpGaD
Exemestane—Urticaria—Triamcinolone—hematologic cancer	1.45e-05	0.000121	CcSEcCtD
Exemestane—Oedema peripheral—Doxorubicin—hematologic cancer	1.45e-05	0.00012	CcSEcCtD
Exemestane—Asthenia—Etoposide—hematologic cancer	1.44e-05	0.00012	CcSEcCtD
Exemestane—Body temperature increased—Triamcinolone—hematologic cancer	1.44e-05	0.00012	CcSEcCtD
Exemestane—Oedema—Prednisone—hematologic cancer	1.44e-05	0.00012	CcSEcCtD
Exemestane—Decreased appetite—Dexamethasone—hematologic cancer	1.44e-05	0.00012	CcSEcCtD
Exemestane—Decreased appetite—Betamethasone—hematologic cancer	1.44e-05	0.00012	CcSEcCtD
Exemestane—Nausea—Mitoxantrone—hematologic cancer	1.44e-05	0.00012	CcSEcCtD
Exemestane—Nausea—Irinotecan—hematologic cancer	1.44e-05	0.00012	CcSEcCtD
Exemestane—Immune system disorder—Epirubicin—hematologic cancer	1.43e-05	0.000119	CcSEcCtD
Exemestane—Infection—Prednisone—hematologic cancer	1.43e-05	0.000119	CcSEcCtD
Exemestane—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.43e-05	0.000119	CcSEcCtD
Exemestane—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.43e-05	0.000119	CcSEcCtD
Exemestane—Back pain—Methotrexate—hematologic cancer	1.43e-05	0.000119	CcSEcCtD
Exemestane—Fatigue—Betamethasone—hematologic cancer	1.43e-05	0.000119	CcSEcCtD
Exemestane—Fatigue—Dexamethasone—hematologic cancer	1.43e-05	0.000119	CcSEcCtD
Exemestane—Pruritus—Etoposide—hematologic cancer	1.42e-05	0.000119	CcSEcCtD
Exemestane—Pain—Betamethasone—hematologic cancer	1.42e-05	0.000118	CcSEcCtD
Exemestane—Pain—Dexamethasone—hematologic cancer	1.42e-05	0.000118	CcSEcCtD
Exemestane—Visual impairment—Doxorubicin—hematologic cancer	1.42e-05	0.000118	CcSEcCtD
Exemestane—Nervous system disorder—Prednisone—hematologic cancer	1.41e-05	0.000118	CcSEcCtD
Exemestane—Alopecia—Epirubicin—hematologic cancer	1.4e-05	0.000117	CcSEcCtD
Exemestane—Skin disorder—Prednisone—hematologic cancer	1.4e-05	0.000117	CcSEcCtD
Exemestane—Nausea—Gemcitabine—hematologic cancer	1.4e-05	0.000117	CcSEcCtD
Exemestane—Vomiting—Cisplatin—hematologic cancer	1.4e-05	0.000116	CcSEcCtD
Exemestane—Hyperhidrosis—Prednisone—hematologic cancer	1.39e-05	0.000116	CcSEcCtD
Exemestane—Mental disorder—Epirubicin—hematologic cancer	1.39e-05	0.000116	CcSEcCtD
Exemestane—Erythema multiforme—Doxorubicin—hematologic cancer	1.39e-05	0.000116	CcSEcCtD
Exemestane—Rash—Cisplatin—hematologic cancer	1.39e-05	0.000115	CcSEcCtD
Exemestane—Dermatitis—Cisplatin—hematologic cancer	1.38e-05	0.000115	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—FOXO1—hematologic cancer	1.38e-05	0.0168	CbGpPWpGaD
Exemestane—Diarrhoea—Etoposide—hematologic cancer	1.38e-05	0.000115	CcSEcCtD
Exemestane—Anorexia—Prednisone—hematologic cancer	1.37e-05	0.000114	CcSEcCtD
Exemestane—Feeling abnormal—Betamethasone—hematologic cancer	1.36e-05	0.000114	CcSEcCtD
Exemestane—Feeling abnormal—Dexamethasone—hematologic cancer	1.36e-05	0.000114	CcSEcCtD
Exemestane—Cardiac disorder—Doxorubicin—hematologic cancer	1.36e-05	0.000113	CcSEcCtD
Exemestane—Gastrointestinal pain—Betamethasone—hematologic cancer	1.35e-05	0.000113	CcSEcCtD
Exemestane—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.35e-05	0.000113	CcSEcCtD
Exemestane—Hypersensitivity—Triamcinolone—hematologic cancer	1.34e-05	0.000112	CcSEcCtD
Exemestane—Back pain—Epirubicin—hematologic cancer	1.34e-05	0.000111	CcSEcCtD
Exemestane—CYP3A4—Irinotecan Pathway—UGT1A1—hematologic cancer	1.33e-05	0.0162	CbGpPWpGaD
Exemestane—Malaise—Methotrexate—hematologic cancer	1.33e-05	0.000111	CcSEcCtD
Exemestane—Dizziness—Etoposide—hematologic cancer	1.33e-05	0.000111	CcSEcCtD
Exemestane—Muscle spasms—Epirubicin—hematologic cancer	1.33e-05	0.000111	CcSEcCtD
Exemestane—Immune system disorder—Doxorubicin—hematologic cancer	1.33e-05	0.00011	CcSEcCtD
Exemestane—Leukopenia—Methotrexate—hematologic cancer	1.32e-05	0.00011	CcSEcCtD
Exemestane—Urticaria—Dexamethasone—hematologic cancer	1.32e-05	0.00011	CcSEcCtD
Exemestane—Urticaria—Betamethasone—hematologic cancer	1.32e-05	0.00011	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.31e-05	0.000109	CcSEcCtD
Exemestane—Dizziness—Prednisolone—hematologic cancer	1.31e-05	0.000109	CcSEcCtD
Exemestane—Asthenia—Triamcinolone—hematologic cancer	1.31e-05	0.000109	CcSEcCtD
Exemestane—Body temperature increased—Dexamethasone—hematologic cancer	1.31e-05	0.000109	CcSEcCtD
Exemestane—Abdominal pain—Dexamethasone—hematologic cancer	1.31e-05	0.000109	CcSEcCtD
Exemestane—Abdominal pain—Betamethasone—hematologic cancer	1.31e-05	0.000109	CcSEcCtD
Exemestane—Body temperature increased—Betamethasone—hematologic cancer	1.31e-05	0.000109	CcSEcCtD
Exemestane—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hematologic cancer	1.31e-05	0.0159	CbGpPWpGaD
Exemestane—Nausea—Cisplatin—hematologic cancer	1.3e-05	0.000109	CcSEcCtD
Exemestane—Insomnia—Prednisone—hematologic cancer	1.3e-05	0.000109	CcSEcCtD
Exemestane—Alopecia—Doxorubicin—hematologic cancer	1.3e-05	0.000108	CcSEcCtD
Exemestane—Paraesthesia—Prednisone—hematologic cancer	1.3e-05	0.000108	CcSEcCtD
Exemestane—Pruritus—Triamcinolone—hematologic cancer	1.29e-05	0.000107	CcSEcCtD
Exemestane—Cough—Methotrexate—hematologic cancer	1.29e-05	0.000107	CcSEcCtD
Exemestane—Mental disorder—Doxorubicin—hematologic cancer	1.29e-05	0.000107	CcSEcCtD
Exemestane—Vomiting—Etoposide—hematologic cancer	1.28e-05	0.000107	CcSEcCtD
Exemestane—Dyspepsia—Prednisone—hematologic cancer	1.27e-05	0.000106	CcSEcCtD
Exemestane—Rash—Etoposide—hematologic cancer	1.27e-05	0.000106	CcSEcCtD
Exemestane—Dermatitis—Etoposide—hematologic cancer	1.27e-05	0.000106	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BAK1—hematologic cancer	1.26e-05	0.0153	CbGpPWpGaD
Exemestane—Headache—Etoposide—hematologic cancer	1.26e-05	0.000105	CcSEcCtD
Exemestane—Myalgia—Methotrexate—hematologic cancer	1.26e-05	0.000105	CcSEcCtD
Exemestane—Arthralgia—Methotrexate—hematologic cancer	1.26e-05	0.000105	CcSEcCtD
Exemestane—Chest pain—Methotrexate—hematologic cancer	1.26e-05	0.000105	CcSEcCtD
Exemestane—Decreased appetite—Prednisone—hematologic cancer	1.25e-05	0.000104	CcSEcCtD
Exemestane—Rash—Prednisolone—hematologic cancer	1.25e-05	0.000104	CcSEcCtD
Exemestane—Dermatitis—Prednisolone—hematologic cancer	1.25e-05	0.000104	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.25e-05	0.000104	CcSEcCtD
Exemestane—Malaise—Epirubicin—hematologic cancer	1.25e-05	0.000104	CcSEcCtD
Exemestane—Fatigue—Prednisone—hematologic cancer	1.24e-05	0.000104	CcSEcCtD
Exemestane—Headache—Prednisolone—hematologic cancer	1.24e-05	0.000104	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—NCOR1—hematologic cancer	1.24e-05	0.015	CbGpPWpGaD
Exemestane—Leukopenia—Epirubicin—hematologic cancer	1.24e-05	0.000103	CcSEcCtD
Exemestane—Back pain—Doxorubicin—hematologic cancer	1.24e-05	0.000103	CcSEcCtD
Exemestane—Constipation—Prednisone—hematologic cancer	1.23e-05	0.000103	CcSEcCtD
Exemestane—Muscle spasms—Doxorubicin—hematologic cancer	1.23e-05	0.000102	CcSEcCtD
Exemestane—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hematologic cancer	1.22e-05	0.0148	CbGpPWpGaD
Exemestane—Confusional state—Methotrexate—hematologic cancer	1.22e-05	0.000101	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	1.21e-05	0.0147	CbGpPWpGaD
Exemestane—Dizziness—Triamcinolone—hematologic cancer	1.21e-05	0.0001	CcSEcCtD
Exemestane—Cough—Epirubicin—hematologic cancer	1.21e-05	0.0001	CcSEcCtD
Exemestane—Infection—Methotrexate—hematologic cancer	1.2e-05	9.97e-05	CcSEcCtD
Exemestane—Nausea—Etoposide—hematologic cancer	1.2e-05	9.95e-05	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—TSC2—hematologic cancer	1.19e-05	0.0145	CbGpPWpGaD
Exemestane—Hypertension—Epirubicin—hematologic cancer	1.19e-05	9.93e-05	CcSEcCtD
Exemestane—Feeling abnormal—Prednisone—hematologic cancer	1.19e-05	9.89e-05	CcSEcCtD
Exemestane—Asthenia—Dexamethasone—hematologic cancer	1.19e-05	9.89e-05	CcSEcCtD
Exemestane—Asthenia—Betamethasone—hematologic cancer	1.19e-05	9.89e-05	CcSEcCtD
Exemestane—Nervous system disorder—Methotrexate—hematologic cancer	1.18e-05	9.84e-05	CcSEcCtD
Exemestane—Thrombocytopenia—Methotrexate—hematologic cancer	1.18e-05	9.82e-05	CcSEcCtD
Exemestane—Gastrointestinal pain—Prednisone—hematologic cancer	1.18e-05	9.82e-05	CcSEcCtD
Exemestane—Nausea—Prednisolone—hematologic cancer	1.18e-05	9.81e-05	CcSEcCtD
Exemestane—Myalgia—Epirubicin—hematologic cancer	1.18e-05	9.8e-05	CcSEcCtD
Exemestane—Arthralgia—Epirubicin—hematologic cancer	1.18e-05	9.8e-05	CcSEcCtD
Exemestane—Chest pain—Epirubicin—hematologic cancer	1.18e-05	9.8e-05	CcSEcCtD
Exemestane—Anxiety—Epirubicin—hematologic cancer	1.17e-05	9.76e-05	CcSEcCtD
Exemestane—Pruritus—Dexamethasone—hematologic cancer	1.17e-05	9.75e-05	CcSEcCtD
Exemestane—Pruritus—Betamethasone—hematologic cancer	1.17e-05	9.75e-05	CcSEcCtD
Exemestane—Skin disorder—Methotrexate—hematologic cancer	1.17e-05	9.75e-05	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.17e-05	9.73e-05	CcSEcCtD
Exemestane—Hyperhidrosis—Methotrexate—hematologic cancer	1.17e-05	9.7e-05	CcSEcCtD
Exemestane—Vomiting—Triamcinolone—hematologic cancer	1.16e-05	9.66e-05	CcSEcCtD
Exemestane—CYP3A4—Irinotecan Pathway—ABCG2—hematologic cancer	1.16e-05	0.014	CbGpPWpGaD
Exemestane—Malaise—Doxorubicin—hematologic cancer	1.15e-05	9.6e-05	CcSEcCtD
Exemestane—Rash—Triamcinolone—hematologic cancer	1.15e-05	9.58e-05	CcSEcCtD
Exemestane—Dermatitis—Triamcinolone—hematologic cancer	1.15e-05	9.57e-05	CcSEcCtD
Exemestane—Anorexia—Methotrexate—hematologic cancer	1.15e-05	9.56e-05	CcSEcCtD
Exemestane—Urticaria—Prednisone—hematologic cancer	1.15e-05	9.54e-05	CcSEcCtD
Exemestane—Leukopenia—Doxorubicin—hematologic cancer	1.14e-05	9.53e-05	CcSEcCtD
Exemestane—Headache—Triamcinolone—hematologic cancer	1.14e-05	9.52e-05	CcSEcCtD
Exemestane—Body temperature increased—Prednisone—hematologic cancer	1.14e-05	9.49e-05	CcSEcCtD
Exemestane—Abdominal pain—Prednisone—hematologic cancer	1.14e-05	9.49e-05	CcSEcCtD
Exemestane—Confusional state—Epirubicin—hematologic cancer	1.14e-05	9.47e-05	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—MAPK14—hematologic cancer	1.14e-05	0.0138	CbGpPWpGaD
Exemestane—Diarrhoea—Dexamethasone—hematologic cancer	1.13e-05	9.43e-05	CcSEcCtD
Exemestane—Diarrhoea—Betamethasone—hematologic cancer	1.13e-05	9.43e-05	CcSEcCtD
Exemestane—CYP3A4—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	1.13e-05	0.0137	CbGpPWpGaD
Exemestane—Oedema—Epirubicin—hematologic cancer	1.13e-05	9.39e-05	CcSEcCtD
Exemestane—Infection—Epirubicin—hematologic cancer	1.12e-05	9.33e-05	CcSEcCtD
Exemestane—Cough—Doxorubicin—hematologic cancer	1.12e-05	9.29e-05	CcSEcCtD
Exemestane—Nervous system disorder—Epirubicin—hematologic cancer	1.11e-05	9.21e-05	CcSEcCtD
Exemestane—Thrombocytopenia—Epirubicin—hematologic cancer	1.1e-05	9.19e-05	CcSEcCtD
Exemestane—Hypertension—Doxorubicin—hematologic cancer	1.1e-05	9.19e-05	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.1e-05	9.14e-05	CcSEcCtD
Exemestane—Skin disorder—Epirubicin—hematologic cancer	1.1e-05	9.12e-05	CcSEcCtD
Exemestane—Dizziness—Betamethasone—hematologic cancer	1.1e-05	9.12e-05	CcSEcCtD
Exemestane—Dizziness—Dexamethasone—hematologic cancer	1.1e-05	9.12e-05	CcSEcCtD
Exemestane—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	1.09e-05	0.0132	CbGpPWpGaD
Exemestane—Hyperhidrosis—Epirubicin—hematologic cancer	1.09e-05	9.08e-05	CcSEcCtD
Exemestane—Insomnia—Methotrexate—hematologic cancer	1.09e-05	9.08e-05	CcSEcCtD
Exemestane—Chest pain—Doxorubicin—hematologic cancer	1.09e-05	9.06e-05	CcSEcCtD
Exemestane—Arthralgia—Doxorubicin—hematologic cancer	1.09e-05	9.06e-05	CcSEcCtD
Exemestane—Myalgia—Doxorubicin—hematologic cancer	1.09e-05	9.06e-05	CcSEcCtD
Exemestane—Anxiety—Doxorubicin—hematologic cancer	1.09e-05	9.03e-05	CcSEcCtD
Exemestane—Nausea—Triamcinolone—hematologic cancer	1.08e-05	9.02e-05	CcSEcCtD
Exemestane—Paraesthesia—Methotrexate—hematologic cancer	1.08e-05	9.01e-05	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.08e-05	9e-05	CcSEcCtD
Exemestane—Anorexia—Epirubicin—hematologic cancer	1.08e-05	8.95e-05	CcSEcCtD
Exemestane—Dyspnoea—Methotrexate—hematologic cancer	1.07e-05	8.95e-05	CcSEcCtD
Exemestane—Hypersensitivity—Prednisone—hematologic cancer	1.06e-05	8.85e-05	CcSEcCtD
Exemestane—Dyspepsia—Methotrexate—hematologic cancer	1.06e-05	8.83e-05	CcSEcCtD
Exemestane—Vomiting—Dexamethasone—hematologic cancer	1.05e-05	8.77e-05	CcSEcCtD
Exemestane—Vomiting—Betamethasone—hematologic cancer	1.05e-05	8.77e-05	CcSEcCtD
Exemestane—Confusional state—Doxorubicin—hematologic cancer	1.05e-05	8.76e-05	CcSEcCtD
Exemestane—Decreased appetite—Methotrexate—hematologic cancer	1.05e-05	8.72e-05	CcSEcCtD
Exemestane—Rash—Dexamethasone—hematologic cancer	1.04e-05	8.69e-05	CcSEcCtD
Exemestane—Rash—Betamethasone—hematologic cancer	1.04e-05	8.69e-05	CcSEcCtD
Exemestane—Oedema—Doxorubicin—hematologic cancer	1.04e-05	8.69e-05	CcSEcCtD
Exemestane—Dermatitis—Dexamethasone—hematologic cancer	1.04e-05	8.68e-05	CcSEcCtD
Exemestane—Dermatitis—Betamethasone—hematologic cancer	1.04e-05	8.68e-05	CcSEcCtD
Exemestane—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.04e-05	8.66e-05	CcSEcCtD
Exemestane—Fatigue—Methotrexate—hematologic cancer	1.04e-05	8.65e-05	CcSEcCtD
Exemestane—Headache—Betamethasone—hematologic cancer	1.04e-05	8.64e-05	CcSEcCtD
Exemestane—Headache—Dexamethasone—hematologic cancer	1.04e-05	8.64e-05	CcSEcCtD
Exemestane—Infection—Doxorubicin—hematologic cancer	1.04e-05	8.63e-05	CcSEcCtD
Exemestane—Asthenia—Prednisone—hematologic cancer	1.03e-05	8.61e-05	CcSEcCtD
Exemestane—Pain—Methotrexate—hematologic cancer	1.03e-05	8.58e-05	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.03e-05	8.55e-05	CcSEcCtD
Exemestane—Nervous system disorder—Doxorubicin—hematologic cancer	1.02e-05	8.52e-05	CcSEcCtD
Exemestane—Thrombocytopenia—Doxorubicin—hematologic cancer	1.02e-05	8.51e-05	CcSEcCtD
Exemestane—Pruritus—Prednisone—hematologic cancer	1.02e-05	8.49e-05	CcSEcCtD
Exemestane—Insomnia—Epirubicin—hematologic cancer	1.02e-05	8.49e-05	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—SLC35B2—hematologic cancer	1.01e-05	0.0123	CbGpPWpGaD
Exemestane—Skin disorder—Doxorubicin—hematologic cancer	1.01e-05	8.44e-05	CcSEcCtD
Exemestane—Paraesthesia—Epirubicin—hematologic cancer	1.01e-05	8.43e-05	CcSEcCtD
Exemestane—Hyperhidrosis—Doxorubicin—hematologic cancer	1.01e-05	8.4e-05	CcSEcCtD
Exemestane—Dyspnoea—Epirubicin—hematologic cancer	1.01e-05	8.37e-05	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—CREB1—hematologic cancer	1e-05	0.0122	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—EPHX1—hematologic cancer	1e-05	0.0121	CbGpPWpGaD
Exemestane—Anorexia—Doxorubicin—hematologic cancer	9.95e-06	8.28e-05	CcSEcCtD
Exemestane—Feeling abnormal—Methotrexate—hematologic cancer	9.93e-06	8.27e-05	CcSEcCtD
Exemestane—Dyspepsia—Epirubicin—hematologic cancer	9.93e-06	8.27e-05	CcSEcCtD
Exemestane—Diarrhoea—Prednisone—hematologic cancer	9.87e-06	8.21e-05	CcSEcCtD
Exemestane—Gastrointestinal pain—Methotrexate—hematologic cancer	9.86e-06	8.2e-05	CcSEcCtD
Exemestane—Nausea—Betamethasone—hematologic cancer	9.84e-06	8.19e-05	CcSEcCtD
Exemestane—Nausea—Dexamethasone—hematologic cancer	9.84e-06	8.19e-05	CcSEcCtD
Exemestane—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	9.82e-06	0.0119	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—ATM—hematologic cancer	9.82e-06	0.0119	CbGpPWpGaD
Exemestane—Decreased appetite—Epirubicin—hematologic cancer	9.81e-06	8.16e-05	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—CDK4—hematologic cancer	9.77e-06	0.0119	CbGpPWpGaD
Exemestane—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.74e-06	8.11e-05	CcSEcCtD
Exemestane—Fatigue—Epirubicin—hematologic cancer	9.73e-06	8.1e-05	CcSEcCtD
Exemestane—Pain—Epirubicin—hematologic cancer	9.65e-06	8.03e-05	CcSEcCtD
Exemestane—Constipation—Epirubicin—hematologic cancer	9.65e-06	8.03e-05	CcSEcCtD
Exemestane—Urticaria—Methotrexate—hematologic cancer	9.58e-06	7.97e-05	CcSEcCtD
Exemestane—Dizziness—Prednisone—hematologic cancer	9.54e-06	7.94e-05	CcSEcCtD
Exemestane—Body temperature increased—Methotrexate—hematologic cancer	9.53e-06	7.93e-05	CcSEcCtD
Exemestane—Abdominal pain—Methotrexate—hematologic cancer	9.53e-06	7.93e-05	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.51e-06	7.92e-05	CcSEcCtD
Exemestane—Insomnia—Doxorubicin—hematologic cancer	9.44e-06	7.86e-05	CcSEcCtD
Exemestane—Paraesthesia—Doxorubicin—hematologic cancer	9.37e-06	7.8e-05	CcSEcCtD
Exemestane—Dyspnoea—Doxorubicin—hematologic cancer	9.31e-06	7.75e-05	CcSEcCtD
Exemestane—Feeling abnormal—Epirubicin—hematologic cancer	9.3e-06	7.74e-05	CcSEcCtD
Exemestane—Gastrointestinal pain—Epirubicin—hematologic cancer	9.22e-06	7.68e-05	CcSEcCtD
Exemestane—Dyspepsia—Doxorubicin—hematologic cancer	9.19e-06	7.65e-05	CcSEcCtD
Exemestane—Vomiting—Prednisone—hematologic cancer	9.17e-06	7.63e-05	CcSEcCtD
Exemestane—Rash—Prednisone—hematologic cancer	9.09e-06	7.57e-05	CcSEcCtD
Exemestane—Dermatitis—Prednisone—hematologic cancer	9.09e-06	7.56e-05	CcSEcCtD
Exemestane—Decreased appetite—Doxorubicin—hematologic cancer	9.07e-06	7.55e-05	CcSEcCtD
Exemestane—Headache—Prednisone—hematologic cancer	9.04e-06	7.52e-05	CcSEcCtD
Exemestane—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.01e-06	7.5e-05	CcSEcCtD
Exemestane—Fatigue—Doxorubicin—hematologic cancer	9e-06	7.49e-05	CcSEcCtD
Exemestane—Urticaria—Epirubicin—hematologic cancer	8.96e-06	7.46e-05	CcSEcCtD
Exemestane—Pain—Doxorubicin—hematologic cancer	8.93e-06	7.43e-05	CcSEcCtD
Exemestane—Constipation—Doxorubicin—hematologic cancer	8.93e-06	7.43e-05	CcSEcCtD
Exemestane—Abdominal pain—Epirubicin—hematologic cancer	8.92e-06	7.42e-05	CcSEcCtD
Exemestane—Body temperature increased—Epirubicin—hematologic cancer	8.92e-06	7.42e-05	CcSEcCtD
Exemestane—Hypersensitivity—Methotrexate—hematologic cancer	8.88e-06	7.39e-05	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	8.82e-06	0.0107	CbGpPWpGaD
Exemestane—Asthenia—Methotrexate—hematologic cancer	8.65e-06	7.2e-05	CcSEcCtD
Exemestane—Feeling abnormal—Doxorubicin—hematologic cancer	8.6e-06	7.16e-05	CcSEcCtD
Exemestane—Nausea—Prednisone—hematologic cancer	8.57e-06	7.13e-05	CcSEcCtD
Exemestane—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.54e-06	7.1e-05	CcSEcCtD
Exemestane—Pruritus—Methotrexate—hematologic cancer	8.53e-06	7.1e-05	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ATR—hematologic cancer	8.53e-06	0.0103	CbGpPWpGaD
Exemestane—Hypersensitivity—Epirubicin—hematologic cancer	8.31e-06	6.92e-05	CcSEcCtD
Exemestane—Urticaria—Doxorubicin—hematologic cancer	8.29e-06	6.9e-05	CcSEcCtD
Exemestane—Body temperature increased—Doxorubicin—hematologic cancer	8.25e-06	6.87e-05	CcSEcCtD
Exemestane—Abdominal pain—Doxorubicin—hematologic cancer	8.25e-06	6.87e-05	CcSEcCtD
Exemestane—Diarrhoea—Methotrexate—hematologic cancer	8.25e-06	6.87e-05	CcSEcCtD
Exemestane—Asthenia—Epirubicin—hematologic cancer	8.09e-06	6.74e-05	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—MTOR—hematologic cancer	8.08e-06	0.0098	CbGpPWpGaD
Exemestane—Pruritus—Epirubicin—hematologic cancer	7.98e-06	6.64e-05	CcSEcCtD
Exemestane—Dizziness—Methotrexate—hematologic cancer	7.97e-06	6.64e-05	CcSEcCtD
Exemestane—Diarrhoea—Epirubicin—hematologic cancer	7.72e-06	6.42e-05	CcSEcCtD
Exemestane—Hypersensitivity—Doxorubicin—hematologic cancer	7.69e-06	6.4e-05	CcSEcCtD
Exemestane—Vomiting—Methotrexate—hematologic cancer	7.66e-06	6.38e-05	CcSEcCtD
Exemestane—Rash—Methotrexate—hematologic cancer	7.6e-06	6.33e-05	CcSEcCtD
Exemestane—Dermatitis—Methotrexate—hematologic cancer	7.59e-06	6.32e-05	CcSEcCtD
Exemestane—Headache—Methotrexate—hematologic cancer	7.55e-06	6.29e-05	CcSEcCtD
Exemestane—Asthenia—Doxorubicin—hematologic cancer	7.49e-06	6.23e-05	CcSEcCtD
Exemestane—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	7.48e-06	0.00907	CbGpPWpGaD
Exemestane—Dizziness—Epirubicin—hematologic cancer	7.46e-06	6.21e-05	CcSEcCtD
Exemestane—Pruritus—Doxorubicin—hematologic cancer	7.38e-06	6.15e-05	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	7.32e-06	0.00888	CbGpPWpGaD
Exemestane—Vomiting—Epirubicin—hematologic cancer	7.17e-06	5.97e-05	CcSEcCtD
Exemestane—Nausea—Methotrexate—hematologic cancer	7.16e-06	5.96e-05	CcSEcCtD
Exemestane—Diarrhoea—Doxorubicin—hematologic cancer	7.14e-06	5.94e-05	CcSEcCtD
Exemestane—Rash—Epirubicin—hematologic cancer	7.11e-06	5.92e-05	CcSEcCtD
Exemestane—Dermatitis—Epirubicin—hematologic cancer	7.11e-06	5.91e-05	CcSEcCtD
Exemestane—Headache—Epirubicin—hematologic cancer	7.07e-06	5.88e-05	CcSEcCtD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	6.97e-06	0.00846	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—NF1—hematologic cancer	6.95e-06	0.00844	CbGpPWpGaD
Exemestane—Dizziness—Doxorubicin—hematologic cancer	6.9e-06	5.75e-05	CcSEcCtD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	6.88e-06	0.00835	CbGpPWpGaD
Exemestane—Nausea—Epirubicin—hematologic cancer	6.7e-06	5.58e-05	CcSEcCtD
Exemestane—Vomiting—Doxorubicin—hematologic cancer	6.64e-06	5.52e-05	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—CDKN1B—hematologic cancer	6.62e-06	0.00803	CbGpPWpGaD
Exemestane—Rash—Doxorubicin—hematologic cancer	6.58e-06	5.48e-05	CcSEcCtD
Exemestane—Dermatitis—Doxorubicin—hematologic cancer	6.58e-06	5.47e-05	CcSEcCtD
Exemestane—Headache—Doxorubicin—hematologic cancer	6.54e-06	5.44e-05	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—GSTO1—hematologic cancer	6.53e-06	0.00793	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—SRC—hematologic cancer	6.47e-06	0.00785	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTO1—hematologic cancer	6.44e-06	0.00782	CbGpPWpGaD
Exemestane—Nausea—Doxorubicin—hematologic cancer	6.2e-06	5.16e-05	CcSEcCtD
Exemestane—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	6.18e-06	0.0075	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—UGT1A1—hematologic cancer	6.14e-06	0.00745	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—NCOA3—hematologic cancer	6.08e-06	0.00737	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—UGT1A1—hematologic cancer	6.06e-06	0.00735	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	6.04e-06	0.00733	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—MAPK3—hematologic cancer	5.96e-06	0.00724	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—PML—hematologic cancer	5.76e-06	0.00699	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—hematologic cancer	5.76e-06	0.00699	CbGpPWpGaD
Exemestane—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	5.73e-06	0.00695	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	5.53e-06	0.00671	CbGpPWpGaD
Exemestane—CYP19A1—Tryptophan metabolism—MDM2—hematologic cancer	5.42e-06	0.00658	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	5.37e-06	0.00652	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—MTR—hematologic cancer	5.33e-06	0.00646	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTT1—hematologic cancer	5.07e-06	0.00615	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	4.44e-06	0.00538	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—STAT1—hematologic cancer	4.24e-06	0.00514	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AR—hematologic cancer	4.1e-06	0.00497	CbGpPWpGaD
Exemestane—CYP19A1—FSH signaling pathway—AKT1—hematologic cancer	4.02e-06	0.00488	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	3.89e-06	0.00473	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ABL1—hematologic cancer	3.81e-06	0.00462	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	3.72e-06	0.00452	CbGpPWpGaD
Exemestane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	3.55e-06	0.00431	CbGpPWpGaD
Exemestane—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	3.52e-06	0.00428	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTP1—hematologic cancer	3.51e-06	0.00426	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—hematologic cancer	3.49e-06	0.00424	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BAX—hematologic cancer	3.49e-06	0.00424	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTP1—hematologic cancer	3.46e-06	0.0042	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—JAK1—hematologic cancer	3.42e-06	0.00415	CbGpPWpGaD
Exemestane—CYP19A1—Biological oxidations—GSTM1—hematologic cancer	3.23e-06	0.00392	CbGpPWpGaD
Exemestane—CYP19A1—Metapathway biotransformation—GSTM1—hematologic cancer	3.18e-06	0.00386	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	3.17e-06	0.00385	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TSC2—hematologic cancer	3.01e-06	0.00365	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CDK2—hematologic cancer	2.99e-06	0.00363	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	2.96e-06	0.00359	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	2.92e-06	0.00354	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ATM—hematologic cancer	2.84e-06	0.00344	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CDK4—hematologic cancer	2.82e-06	0.00343	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ESR1—hematologic cancer	2.81e-06	0.00341	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.77e-06	0.00337	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BAD—hematologic cancer	2.75e-06	0.00333	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GMPS—hematologic cancer	2.69e-06	0.00327	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PHYH—hematologic cancer	2.69e-06	0.00327	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—FTCD—hematologic cancer	2.69e-06	0.00327	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.66e-06	0.00323	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.54e-06	0.00308	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CREB1—hematologic cancer	2.53e-06	0.00307	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.51e-06	0.00304	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BRAF—hematologic cancer	2.5e-06	0.00303	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP8—hematologic cancer	2.48e-06	0.00301	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SMPD3—hematologic cancer	2.46e-06	0.00299	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—RB1—hematologic cancer	2.46e-06	0.00298	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.46e-06	0.00298	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.29e-06	0.00278	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.24e-06	0.00271	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—DCK—hematologic cancer	2.15e-06	0.00261	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—B3GAT1—hematologic cancer	2.15e-06	0.00261	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ASNS—hematologic cancer	2.15e-06	0.00261	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	2.13e-06	0.00258	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.1e-06	0.00255	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	2.09e-06	0.00254	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HDC—hematologic cancer	2.04e-06	0.00247	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	2.04e-06	0.00247	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	1.91e-06	0.00231	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.9e-06	0.00231	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	1.88e-06	0.00228	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	1.87e-06	0.00227	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CDA—hematologic cancer	1.87e-06	0.00226	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	1.82e-06	0.00221	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—JUN—hematologic cancer	1.82e-06	0.00221	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PC—hematologic cancer	1.8e-06	0.00218	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	1.79e-06	0.00218	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.77e-06	0.00215	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	1.76e-06	0.00214	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC35B2—hematologic cancer	1.73e-06	0.0021	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GBA—hematologic cancer	1.73e-06	0.0021	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EP300—hematologic cancer	1.68e-06	0.00204	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	1.59e-06	0.00193	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTAP—hematologic cancer	1.59e-06	0.00192	CbGpPWpGaD
Exemestane—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.58e-06	0.00192	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.55e-06	0.00189	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.48e-06	0.00179	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MYC—hematologic cancer	1.46e-06	0.00178	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—FHL2—hematologic cancer	1.41e-06	0.00172	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AGRN—hematologic cancer	1.39e-06	0.00168	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	1.35e-06	0.00164	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—IDH2—hematologic cancer	1.31e-06	0.00159	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HMMR—hematologic cancer	1.31e-06	0.00159	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.24e-06	0.0015	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ARNTL—hematologic cancer	1.24e-06	0.0015	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ACP5—hematologic cancer	1.2e-06	0.00146	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CA9—hematologic cancer	1.2e-06	0.00146	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—hematologic cancer	1.2e-06	0.00146	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOR2—hematologic cancer	1.19e-06	0.00144	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—IDH1—hematologic cancer	1.13e-06	0.00137	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTO1—hematologic cancer	1.12e-06	0.00136	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCC3—hematologic cancer	1.12e-06	0.00136	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—TXN—hematologic cancer	1.12e-06	0.00136	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SPHK1—hematologic cancer	1.09e-06	0.00133	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—UGT1A1—hematologic cancer	1.05e-06	0.00127	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.02e-06	0.00124	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SLC22A1—hematologic cancer	1.02e-06	0.00124	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CRABP1—hematologic cancer	1.02e-06	0.00124	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	1.01e-06	0.00123	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.01e-06	0.00123	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALOX5—hematologic cancer	9.96e-07	0.00121	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NUP98—hematologic cancer	9.64e-07	0.00117	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	9.42e-07	0.00114	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ADCY7—hematologic cancer	9.36e-07	0.00114	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOA3—hematologic cancer	9.36e-07	0.00114	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NUP214—hematologic cancer	9.3e-07	0.00113	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	9.29e-07	0.00113	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.2e-07	0.00112	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTR—hematologic cancer	9.11e-07	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCG2—hematologic cancer	9.11e-07	0.00111	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ENO2—hematologic cancer	8.93e-07	0.00108	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTT1—hematologic cancer	8.66e-07	0.00105	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.53e-07	0.00104	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SDC1—hematologic cancer	8.47e-07	0.00103	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.09e-07	0.000982	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.98e-07	0.000969	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—FTCD—hematologic cancer	7.85e-07	0.000953	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PHYH—hematologic cancer	7.85e-07	0.000953	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GMPS—hematologic cancer	7.85e-07	0.000953	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.64e-07	0.000927	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NQO1—hematologic cancer	7.2e-07	0.000874	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CD44—hematologic cancer	7.2e-07	0.000874	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SMPD3—hematologic cancer	7.18e-07	0.000872	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.05e-07	0.000856	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYCS—hematologic cancer	6.81e-07	0.000827	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—HSP90AA1—hematologic cancer	6.77e-07	0.000822	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—DCK—hematologic cancer	6.28e-07	0.000762	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ASNS—hematologic cancer	6.28e-07	0.000762	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—B3GAT1—hematologic cancer	6.28e-07	0.000762	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.09e-07	0.000739	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTP1—hematologic cancer	6.01e-07	0.000729	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HDC—hematologic cancer	5.95e-07	0.000722	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.81e-07	0.000705	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ABCB1—hematologic cancer	5.68e-07	0.00069	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NCOR1—hematologic cancer	5.52e-07	0.00067	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—GSTM1—hematologic cancer	5.52e-07	0.00067	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CDA—hematologic cancer	5.44e-07	0.000661	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PC—hematologic cancer	5.24e-07	0.000636	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.06e-07	0.000614	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GBA—hematologic cancer	5.06e-07	0.000614	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTHFR—hematologic cancer	4.88e-07	0.000592	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTAP—hematologic cancer	4.63e-07	0.000562	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.3e-07	0.000522	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—FHL2—hematologic cancer	4.12e-07	0.000501	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CG—hematologic cancer	4.1e-07	0.000497	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AGRN—hematologic cancer	4.05e-07	0.000491	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—IDH2—hematologic cancer	3.83e-07	0.000465	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HMMR—hematologic cancer	3.83e-07	0.000465	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CREBBP—hematologic cancer	3.8e-07	0.000461	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.61e-07	0.000438	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CD—hematologic cancer	3.6e-07	0.000437	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—ALB—hematologic cancer	3.56e-07	0.000432	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ACP5—hematologic cancer	3.51e-07	0.000426	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CA9—hematologic cancer	3.51e-07	0.000426	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.46e-07	0.00042	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3R1—hematologic cancer	3.4e-07	0.000413	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—IDH1—hematologic cancer	3.3e-07	0.0004	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—TXN—hematologic cancer	3.26e-07	0.000396	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.26e-07	0.000396	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.26e-07	0.000396	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.19e-07	0.000387	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CB—hematologic cancer	3.14e-07	0.000381	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.07e-07	0.000372	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.98e-07	0.000362	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.98e-07	0.000362	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.91e-07	0.000353	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NUP98—hematologic cancer	2.81e-07	0.000342	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.73e-07	0.000332	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.73e-07	0.000332	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NUP214—hematologic cancer	2.71e-07	0.000329	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTEN—hematologic cancer	2.71e-07	0.000329	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.66e-07	0.000323	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTR—hematologic cancer	2.66e-07	0.000323	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ENO2—hematologic cancer	2.61e-07	0.000316	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—EP300—hematologic cancer	2.59e-07	0.000314	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.53e-07	0.000307	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SDC1—hematologic cancer	2.47e-07	0.0003	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NQO1—hematologic cancer	2.1e-07	0.000255	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CD44—hematologic cancer	2.1e-07	0.000255	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYCS—hematologic cancer	1.99e-07	0.000241	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.98e-07	0.00024	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CA—hematologic cancer	1.91e-07	0.000232	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.75e-07	0.000213	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.66e-07	0.000201	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.61e-07	0.000195	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.61e-07	0.000195	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—hematologic cancer	1.56e-07	0.00019	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.42e-07	0.000173	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.2e-07	0.000145	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.11e-07	0.000135	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.05e-07	0.000128	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—ALB—hematologic cancer	1.04e-07	0.000126	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.93e-08	0.00012	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.16e-08	0.000111	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTEN—hematologic cancer	7.92e-08	9.61e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—EP300—hematologic cancer	7.55e-08	9.16e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.59e-08	6.78e-05	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—hematologic cancer	4.56e-08	5.54e-05	CbGpPWpGaD
